Despite global declines in under-five and infant mortality rates in recent decades, neonatal mortality rates have remained relatively unchanged.
Despite global declines in under-five and infant mortality rates in recent decades, neonatal mortality rates have remained relatively unchanged. 1 Mortality during the first 28 days of life now accounts for two-thirds of deaths in children less than 1 year of age, and nearly four-tenths of all deaths in children less than 5 years of age. 2 -4 A recent analysis found that the loss of healthy life from newborn deaths represented 8.2% and 13.6% of the burden of disease in Sub-Saharan Africa and South Asia, respectively, or 27 and 53 million years of life lost in those two respective regions alone. 5 The analysis, however, highlighted the dearth of information available on neonatal outcomes in developing countries, particularly at the community level, and the potential for currently available figures to underestimate the magnitude of the problem. Thus, epidemiological research is needed to make available more accurate data on risk factors and causes of neonatal morbidity and mortality, and improved and validated neonatal verbal autopsy instruments are needed in order to collect accurate data.
For every death during the neonatal period, it is estimated that another stillbirth has occurred; when combined with the two-thirds of neonatal deaths that occur during the first week of life, perinatal deaths nearly equal the number of deaths during the entire first year of life. 6, 7 Estimates from the World Bank suggest that perinatal deaths account for approximately 7% of the global burden of disease, exceeding that due to malaria and vaccine-preventable infections combined. 8 Worldwide, 98% of all neonatal deaths occur in developing countries, most often at home, outside the formal health care system, and largely due to infections (32%), birth asphyxia and injuries (29%), and consequences of prematurity and congenital anomalies (34%). 9 Infections may account for approximately half of newborn deaths at the community level. 10 Low birth weight (LBW) is an overriding factor in the majority of the deaths. 1 Conditions that affect the neonate, including LBW, impact not only neonatal mortality but also long-term morbidity through effects on neurological and cognitive development and associations with chronic diseases such as diabetes, cardiovascular disease and chronic lung disease. 11 Thus, interventions that prevent morbidity during the neonatal period have the potential to be highly cost-effective and impact health far beyond the neonatal period.
In this review, we present a conceptual framework for maternal and neonatal health care, and in this context, propose priority research activities to improve perinatal and neonatal health and survival in developing country communities.
CONCEPTUAL FRAMEWORK AND CONTEXT OF NEONATAL HEALTH CARE AND RESEARCH
Improving newborn health and survival depends in large measure on more effectively implementing what we already know works.
Although many advances in obstetric and neonatal care are costly and require technology not available in resource-poor countries, a substantial proportion of perinatal and neonatal morbidity and mortality in developing countries could be prevented through appropriate adaptations and applications of inexpensive, relatively simple methods to improve antenatal, obstetric and neonatal care. In many cases, however, further research is needed to devise, adapt and evaluate sustainable solutions, particularly at the community level.
Currently, most newborn deaths in developing country communities are due to failure to: (1) identify and address socioeconomic, cultural and logistical barriers to proper maternal and newborn care and care seeking; (2) implement basic preventive measures (e.g., administration of tetanus toxoid, early exclusive breastfeeding); and, (3) promptly identify and manage sick newborns. Save the Children Federation-US has developed a conceptual framework for household and community newborn and maternal care that focuses attention on: (1) use of routine maternal and newborn care and services of good quality; (2) response to maternal danger signs; (3) response to the non-breathing newborn; (4) care for the LBW baby; and, (5) response to newborn danger signs, particularly those of infection (Figure 1) . 12 This framework emphasizes that, because the health of the mother and the newborn Figure 1 . Conceptual framework of maternal and neonatal care, emphasizing the need to focus on ( upper panel ) adaptation and expanded implementation of essential maternal and newborn care measures, and, ( lower panel ) major determinants of perinatal and neonatal morbidity and mortality, particularly care of the LBW infant; and recognition of and appropriate response to maternal and neonatal danger signs, particularly those signaling birth asphyxia and neonatal infections.
are inextricably linked, intervention strategies must encompass antenatal and intrapartum health care of the mother and immediate and routine postpartum care of the mother and neonate to optimally impact perinatal and neonatal health outcomes. Strategies to reduce neonatal morbidity and mortality also must be implemented within and integrated into a sustainable health system infrastructure. Relatively more emphasis, for example, must be placed on integration of neonatal health care into safe motherhood and child survival programs. Moreover, because the majority of births and neonatal deaths occur in the home, there is an urgent need to understand traditional maternal and newborn care practices and illness recognition and care-seeking behavior for the newborn in the community. Mothers must be aided in understanding their crucial role in maintaining good health during pregnancy and the health of their infant after birth, and must be empowered and equipped to seek and obtain appropriate care for themselves and their newborn. Similarly, health care providers at all levels must be better educated on essential newborn care; and closer links between the home, health center and regional hospital must be forged. It is also imperative that researchers anticipate how their findings can be translated into programs and communicate closely from the outset with those who will be responsible (e.g., governmental officials, stakeholders, program managers) for prioritizing scarce resources and integrating and locally adapting interventions into existing programs. However, when considering where to invest in research, funding agencies should adhere to criteria that ensure these principles have been considered in the study's conception and design (Table 1) .
Major areas of research needed to advance newborn health and survival include: (1) epidemiological research to identify contributing factors in newborn deaths; (2) formative research to better understand current local beliefs and practices and the reasons for them, so that effective behavior change strategies can be developed and evaluated; (3) operations research to better understand how to deliver affordable, proven, life-saving preventative and curative care; (4) community-based effectiveness trials of promising models of maternal and newborn care; and, (5) trials aimed to advance the state of the art in selected aspects of community-based essential newborn health monitoring and care. In this report, we highlight current knowledge and gaps in understanding, as a foundation for outlining priority future research ( 6 ) Feasibility and affordability of the research project in the local setting ( 7 ) Projected feasibility and affordability of adaptation, replication and scaling -up of the intervention being tested in a programmatic context, for example, feasibility and affordability of sustained integration of the intervention( s ) into the health care system ( 8 ) Population / culturally appropriate ( 9 ) Has support from policymakers, stakeholders and program managers within the country and community in which the research will be conducted o Evaluate the efficacy of empiric antibiotic therapy for treatment of urinary tract infections and sexually transmitted infections, and after premature or prolonged rupture of membranes to reduce premature birth o Conduct surveillance studies to establish the prevalence and etiology of bacterial vaginosis in developing countries, and evaluate simple diagnostic methods and treatment algorithms o Develop, implement, and evaluate strategies to prevent and treat malaria in pregnant women as part of routine antenatal care in areas of high malaria endemicity, including the integration into routine antenatal care of intermittent treatment for the prevention of malaria in pregnant women o Develop optimal strategies to prevent perinatal and breast milk transmission of HIV ( see below )
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Improving Perinatal and Neonatal Outcomes (see Tables 1-6 ) in each of the major programmatic phases of maternal and newborn care ( Figure 1 ).
MATERNAL HEALTH AND ANTENATAL CARE
Research activities to enhance maternal health and antenatal care ( Table 2) can have a profound effect on reducing perinatal and neonatal morbidity and mortality. 13 Overall, pregnancy and delivery complications are implicated in more than half of newborn deaths.
2,4
Maternal Education and the Status of Women The relationship between maternal education and perinatal and neonatal mortality is complex but several studies have demonstrated reduced rates of infant and child mortality in association with increased levels of maternal education. 14, 15 This association is partly explained by the economic advantages and access to health care afforded by education. Potential links between maternal education and reduced perinatal and neonatal mortality also include appropriate birth spacing and health-seeking behavior, particularly for prenatal care. Infants born to mothers who do not receive prenatal care have nearly a 25% increase in neonatal mortality, and the risk of perinatal mortality is highest in women with very short and very long intervals between pregnancies. 16 Fundamental to enhancing maternal health and capacity is the promotion of gender equality and improvement of women's status in the home and the community. Gender bias may also impact adversely on the care provided to female newborns, although greater understanding is needed of contributing factors, its cultural context and ways to effect change.
Maternal Nutrition
Poor maternal nutrition before and during pregnancy impacts adversely on pregnancy outcome and infant survival, and can o Develop strategies to ensure universal skilled care at delivery o Conduct community-based studies to determine traditional birth practices; knowledge, attitudes and beliefs regarding routine obstetric practices; and sociocultural factors that impact health-seeking behavior for obstetric care o Evaluate birth attendant training curricula, continuing medical education and quality assurance o Identify barriers to, and evaluate strategies to improve quality and access to emergency obstetric care o Define the role of chlorhexidine cleansing of the birth canal and/or the newborn in prevention of neonatal umbilical cord and skin infections, and septicemia Prevention and management of HIV infection o Define cost-effective strategies to prevent mother-to-child HIV transmission, for example, single-dose nevirapine; impact of short-course treatment on later transmission via breastfeeding; need for longer courses of therapy plus early weaning; role of combination regimens; appropriate target population (e.g., all pregnant women or those with documented infection) in settings with various levels of health care infrastructure and resources (e.g., rapid testing and counseling available) o Define optimal breastfeeding strategies in areas with high HIV prevalence o Define HIV case definition and prognostic criteria, strategies for primary prophylaxis of opportunistic infections and severe bacterial infections, vaccination schedules (e.g., possible need to withhold BCG, immunological response to vaccines), role of micronutrient supplementation in high-risk infants o Define the role of chlorhexidine cleansing of the birth canal and/or the newborn in prevention of mother-to-child HIV transmission Table 4 Research to Improve Neonatal Care: Immediate Postpartum Interventions
Birth asphyxia, hypoglycemia, hypothermia o Determine neonatal encephalopathy rates and outcomes (disabilities) in the community o Develop and evaluate simple and inexpensive prenatal and obstetric interventions to reduce the risk of birth asphyxia o Evaluate the ability of traditional birth attendants and community health workers to identify and successfully resuscitate asphyxiated neonates using simple methods such as tactile stimulation and clearing of upper airway secretions using an oral mucus suction trap, and artificial breathing using a mouth-to-mask, tube-and-mask, or bag-mask technique o Develop strategies (e.g., behavioral change communication) to reduce the incidence of hypothermia and hypoglycemia through such interventions as proper drying and swaddling, immediate and exclusive breastfeeding, recognition and rewarming of hypothermic neonates, cultural adaptation of skin-to-skin contact o Evaluate the acceptability, safety, and impact of Kangaroo Mother Care in the home, in nurseries with limited resources, and in critically ill, preterm and very LBW neonates Breastfeeding o Determine underlying factors that influence decisions regarding breastfeeding o Devise and evaluate culturally sensitive strategies for promoting early, exclusive breastfeeding, particularly for LBW newborns result in spontaneous abortion, stillbirth, congenital malformation, intrauterine growth retardation (IUGR), preterm delivery and perinatal and neonatal death. 17 Malnutrition also increases the risk of maternal infection, which further impacts on perinatal and neonatal morbidity and mortality. Because much of brain growth occurs during late pregnancy and early infancy, maternal malnutrition also can impair early childhood development. 18 Improving the nutritional status of pregnant women through supplemental feeding, dietary fortification, food distribution, and nutrition counseling has received renewed attention following results obtained recently in The Gambia. A package of interventions including locally produced nutritional supplements (i.e., biscuits) was targeted toward pregnant women, and reduced LBW from 17% to 11% and rates of perinatal and early neonatal mortality by 49% and 40%, respectively. 19 Although encouraging, these findings require confirmation with culturally appropriate interventions in different settings, and research needs to focus on developing feasible and sustainable approaches to improving maternal dietary intake during pregnancy.
Several approaches to reducing maternal anemia, including iron supplementation and treatment with antihelminths or antimalarials, also are effective in reducing LBW and perinatal and neonatal mortality. 20 -22 Severe anemia contributes significantly to maternal mortality, 23 and interventions to reduce it will likely decrease both maternal and neonatal deaths. Additional data are particularly needed on whether these interventions will reduce perinatal and neonatal mortality in less severely anemic pregnant women.
Research in recent years has demonstrated that reductions in perinatal and neonatal morbidity and mortality may also be achieved through interventions to reduce maternal micronutrient deficiencies. 24 Maternal supplementation with iodine and folate is well known to reduce hypothyroidism and neural tube defects, respectively. Maternal zinc supplementation may also have beneficial effects on maternal and infant health. 25 In Peru, zinc supplementation during pregnancy enhanced fetal neurological 26 Another study in Bangladesh found decreased incidence of diarrhea and skin infections in LBW infants of mothers provided supplemental zinc during pregnancy. 27 Maternal vitamin A supplementation significantly reduced maternal mortality in Nepal by 40%, 28 although there was no impact on infant mortality through age 6 months. 29 Vitamin A supplementation early in the newborn period, however, is under evaluation as a potentially promising approach. 30 Several trials suggest calcium supplementation can lower rates of preterm delivery and might be effective in preventing pre-eclampsia. 18, 24 The Cochrane group has concluded that calcium supplements may prove beneficial in areas with marginal calcium intakes. 31 Zinc and vitamin C are critical for maintaining the integrity of the amnion, 32 and premature rupture of membranes is an important cause of LBW and perinatal and neonatal mortality. Studies are needed to assess whether supplementation with these nutrients prevents premature rupture of membranes in developing countries. Recently, maternal supplementation with mixtures of multiple nutrients has received attention as a potentially cost-effective strategy for improving both maternal and neonatal health and survival, but little data are yet available on impact. Multivitamin and mineral supplementation to low-income urban women in the United States during pregnancy reduced the risk of LBW by 44%, of preterm delivery before 34 weeks' gestation by 39%, and IUGR by 43%. 33 Further studies in different settings are necessary to confirm these findings.
Maternal Immunity and Immunization
Immunization of pregnant women to enhance maternal immunity and the transplacental transfer of antibodies to the fetus is an effective strategy for the prevention of neonatal tetanus. Despite recommendations on the use of tetanus toxoid in pregnant women and women of childbearing age, average worldwide coverage (measured by the indicator for two doses of tetanus toxoid, ''TT2'') is only 65%, and between 300,000 and 400,000 cases of neonatal tetanus occur each year, resulting in approximately 248,000 deaths in 1997. 34 Increased understanding of sociocultural barriers, leading to improved access to prenatal care and TT are simple and inexpensive measures to reduce the substantial number of deaths due to tetanus.
The high incidence of infectious diseases in young infants in developing countries suggests that in many cases, maternally derived antibodies fail to provide adequate protection. For example, infection with Streptococcus pneumoniae accounts for 10% of deaths (220,000 deaths per annum) globally in infants less than 90 days of age. 35 The high incidence of invasive pneumococcal disease in early infancy may reflect maternal-to-fetal transfer of insufficient levels of, or poorly functioning, anti-capsular pneumococcal antibodies. Knowledge of the pathophysiology of maternal-fetal transfer of anti-capsular antibody is critical to developing maternal and neonatal immunization strategies, as variable amounts of transplacentally acquired antibody may render neonates susceptible to disease or interfere with the response to early immunization. Immunization of pregnant women with either a pneumococcal or Haemophilus influenzae type b polysaccharide vaccine has been shown to transfer sufficient antibody to protect the infant from disease during the neonatal period, 36 although efficacy trials of immunization before or during pregnancy with these vaccines have not yet been reported.
Maternal Infection
LBW is a principal contributor to neonatal morbidity and mortality. Up to 70% or more of neonatal deaths in some countries, such as India and Bangladesh, occur in infants with LBW. 37 Approximately two-thirds of infants in most developing countries with LBW suffer from IUGR, whereas in developed countries, the majority of infants with LBW are born prematurely. 38 Risk factors for IUGR include low pre-pregnancy maternal weight and height, low caloric intake during pregnancy, pre-eclampsia, and maternal infection, especially malaria. 39 Preterm births may be responsible for one-quarter of all perinatal deaths and one-quarter of all deaths among LBW infants in the developing world, due to similar causes as for term, appropriate-for-gestational-age infants. 7 Several strategies have the potential to reduce premature and LBW births in developing countries. Administration of antibiotics to pregnant women with prolonged rupture of membranes may prolong the time until labor and lessen the risk of preterm birth. 40 Urinary tract infections and sexually transmitted diseases, including HIV, syphilis, gonorrhea and chlamydia have been associated with increased risk of premature birth. 41 Several trials have confirmed that treating asymptomatic bacteriuria and symptomatic urinary tract infections may reduce the incidence of premature birth. 18 Moreover, the condition of bacterial vaginosis, which involves replacement of the normal Lactobacillus-predominant flora with other organisms, occurs in up to 16% of women in the United States, and is associated with a 40% increased risk of preterm delivery. 42 Antibiotic treatment of bacterial vaginosis in pregnant women in the United States who previously had a preterm delivery significantly reduced the risk of a subsequent preterm birth. 43 Some studies have found high rates of bacterial vaginosis in developing countries, 44 but data are lacking on the attributable risk for LBW and the impact of simple treatment regimens for bacterial vaginosis in developing countries.
Malaria infection causes severe complications during pregnancy and is a major public health problem in many developing countries. 45 In settings of moderate to high endemicity, malaria may cause up to 30% of preventable LBW in newborns and account for 3% to 5% of neonatal mortality. 46 In settings of low endemicity, malaria is associated with an increased risk of spontaneous abortion and stillbirth. Presumptive treatment of pregnant women in Kenya with sulfadoxine-pyrimethamine resulted in a protective efficacy of 85% for maternal parasitemia, 39% for severe anemia, 22% for perinatal deaths and 38% for neonatal mortality. 22 In Malawi, two doses of sulfadoxine-pyrimethamine administered during the second and third trimesters resulted in reductions in rates of LBW and preterm infants from 27% to 17% and 31% to 21%, respectively. 47 Despite World Health Organization (WHO) recommendations that antimalarial drugs be given for prevention of malaria in pregnant women in endemic areas, 48 many pregnant women at risk do not receive appropriate prevention or treatment as part of prenatal care. Although chloroquine is safe for the treatment of susceptible Plasmodium falciparum in pregnant women, a variety of alternate regimens might be considered for the treatment of pregnant women infected with chloroquine-resistant P. falciparum. However, the efficacy and effectiveness of these regimens are not fully understood, and are likely to change under local drug pressure. Alternative interventions are currently available (e.g., insecticide-impregnated bed nets in areas of low malaria transmission) 49, 50 and others are under development (e.g., vaccines, new drugs); their role in malaria prevention in pregnancy requires evaluation. Potential interactions with other factors, such as concurrent HIV infection 51 or other causes of maternal anemia, also may affect the efficacy of intervention strategies and require further evaluation.
Although the devastating impact of HIV infection on health care and educational systems, particularly in areas of Sub-Saharan Africa, cannot be underestimated, the impact of maternal HIV infection on perinatal and neonatal outcomes is not yet well defined. Maternal HIV infection, however, appears to be associated with increased risk of spontaneous abortion, stillbirth, preterm birth, and IUGR. 52 Administration of a single dose of nevirapine to mothers at onset of labor and to their newborns within 72 hours of delivery reduced mother-to-infant transmission of HIV during the first 14 to 16 weeks of life by almost 50% compared to short-course zidovudine therapy. 53 However, the impact of this regimen on later transmission associated with breastfeeding remains to be addressed. Because the cumulative risk of transmission through breastfeeding increases with time, 54 there may be a need for longer courses of antiviral therapy, perhaps in combination with early weaning. In South Africa, exclusive breastfeeding was associated with a significantly lower risk of HIV transmission than mixed feeding, although this relationship needs to be further evaluated prospectively. 55 
INTRAPARTUM CARE
Nearly two-thirds of all births in developing countries occur at home, and in approximately half of deliveries, skilled care is not available. 4 Skilled care at delivery has been associated historically with lower neonatal mortality rates, 56 but provision for skilled attendance at delivery and management of obstetric emergencies is a first-order operational challenge. Reduction in perinatal and neonatal mortality as a consequence of improved detection and management of complicated labor requires a functioning referral system and the availability of a hierarchy of trained and supervised health care providers, including home or dispensary care provided by skilled community-based delivery attendants; trained midwives and/or nurses at first-line health facilities; and physicians trained in emergency obstetric care at district or regional hospitals. Meanwhile, priority research activities to improve labor and delivery care (Table 3) include education of pregnant women and their families in essential elements of clean and safe delivery, and recognition of maternal and newborn danger signs. Interventions to train, monitor, and supervise community health care workers in the recognition of complications of labor and delivery, and in appropriate referral of women with these problems also are priorities.
IMMEDIATE NEWBORN CARE
Approximately two-thirds of all neonatal mortality occurs in the first week of life, emphasizing the importance of care, and research to improve care, given in the early postpartum period (i.e., the first week of life) ( Table 4 ). In general, however, postpartum visitation for the newborn is largely unknown in many developing countries. Moreover, cultural practices often prescribe a period of seclusion for the mother and newborn, placing further constraints on receiving and seeking care. Thus, developing a better understanding of home care practices, leading to effective behavior change communication strategies to promote healthy behaviors while discouraging harmful practices, is a priority.
Birth Asphyxia, Hypoglycemia, and Hypothermia Intrapartum asphyxia is a major cause of perinatal and neonatal morbidity and mortality. An estimated 4 to 9 million cases of birth asphyxia occur each year, accounting for 24% to 61% of all perinatal mortality. 57 Proper resuscitation, however, is provided to only an estimated 1 to 2 million neonates, and an estimated 1.2 million newborns die annually of birth asphyxia. 58 In Zimbabwe, preventable causes were identified in three-quarters of newborns with birth asphyxia. 59 At delivery, most neonates can be successfully resuscitated by simple techniques such as tactile stimulation and, in some cases, clearing of upper airway secretions using a gauze-covered finger or oral mucus trap. 60 The need for mouth-to-mask, tube-and-mask or bag-mask ventilation is exceptional, and can be accomplished using room air. 61 Extensive efforts to train physicians in neonatal resuscitation, for example using WHO and American Academy of Pediatrics-American Heart Association Neonatal Resuscitation Program materials, are underway in many developing countries, and are showing encouraging results in influencing behavior. 62, 63 Few studies, however, especially community-based studies, have assessed the risk factors, causes and sequelae of birth asphyxia in developing countries, and few have evaluated appropriate methods to train health workers and family members at the community level to recognize birth asphyxia and provide simple interventions and support.
Hypothermia and hypoglycemia may be prevented through simple and inexpensive interventions. Risk factors for hypoglycemia include birth asphyxia, prematurity and hypothermia. 64 Hypothermia is common in developing countries, affecting more than half of all
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Improving Perinatal and Neonatal Outcomes newborns in many communities, and is associated with an increased risk of mortality. 65 -67 Hypothermia also is associated with increased rates of morbidity, including increased risk of neonatal infections, coagulation defects, acidosis, delayed fetal-to-newborn circulatory adjustment, hyaline membrane disease, and brain hemorrhage. 68, 69 Hypothermia can be prevented by simple measures such as ensuring a warm environment during delivery; early breastfeeding and skinto-skin contact with the mother; proper bathing, drying and swaddling; and prompt identification and rewarming of hypothermic neonates. Basic knowledge and practice of thermal control, however, generally are inadequate among health care providers and families in developing countries. 70 Kangaroo Mother Care, in essence skin-to-skin contact between neonate and the mother, is a low-technology, inexpensive measure that affords significant potential benefit, particularly among hospitalized LBW neonates, including promotion of breastfeeding and mother-infant bonding, improved thermal control, faster growth, lower frequency of illness including some infections, shorter duration of hospital stay, and stabilization of physiologic and behavioral functioning. 71 Randomized controlled trials have not been conducted, however, on the impact of Kangaroo Mother Care in the home on neonatal or infant mortality.
Breastfeeding A wide variety of benefits of breastfeeding have been well documented, including reduced risk of hypothermia, hypoglycemia, necrotizing enterocolitis, omphalitis, acute respiratory infections, diarrhea, septicemia, and mortality, particularly in the late neonatal period. 72 Moreover, replacement of colostrum with pre-lacteal feeds increased the risk of neonatal mortality in The Gambia, 73 and mixed supplemental feeding was associated with increased rates of diarrhea, 74, 75 respiratory illness, 76, 77 and mother-to-child transmission of HIV. 78 Although breastfeeding is common, immediate and exclusive breastfeeding, despite its benefits, is not normal practice in many developing countries, particularly for LBW newborns. 79 Recent community-based behavior change research shows promise in increasing immediate initiation of breastfeeding and exclusive breastfeeding to 3 to 6 months of age. 80 -82 Further emphasis must be placed on programmatic implementation of early, exclusive breastfeeding through enhanced understanding of barriers, leading to effective implementation of culturally sensitive behavioral change communication strategies. 83 Further research also is needed to more precisely define the role of breastfeeding in areas of high HIV prevalence. 84 Formative research from Zambia suggests many women are reluctant to stop breastfeeding for fear of being stigmatized as HIV infected. 85 A recent pooled analysis of data from six developing countries showed a six-fold increase in mortality due to infectious diseases in the first 2 months of life among those not breastfed, and declining levels of protection with increasing maternal schooling suggested that it may be difficult, if not impossible to provide safe breast milk substitutes to children from underprivileged populations. 86 
POSTPARTUM NEWBORN CARE
Several simple neonatal care practices in the home promoted and/ or instituted by skilled caregivers, traditional birth attendants and/ or community health workers can markedly reduce neonatal morbidity and mortality. 6, 87, 88 These practices include thermal control to prevent and treat hypothermia; exclusive breastfeeding; antibiotic prophylaxis of ophthalmia neonatorum; hygienic skin and umbilical cord care; surveillance for, special care for and identification of illness in LBW infants; and recognition and management of infections. Further operational research is needed to locally adapt and to understand barriers to implementation of these interventions, and to make them more widely available (Table 5 ).
Skin Care
Epithelial barriers provide first-line defense against invasion of pathogenic organisms, but are developmentally immature, easily injured, and often functionally compromised in neonates, particularly premature infants who account for approximately one-fourth of all mortality in LBW infants. 89 Little is known, however, about the impact of routine skin care practices on neonatal health, including bathing, vernix removal, oil massage, the impact of interventions to enhance skin barrier function, or the role of topical antiseptic agents on rates of infection.
-91
Umbilical Cord Care Proper umbilical cord care reduces bacterial colonization and infection of the cord as well as neonatal tetanus and sepsis. 92 Several antibacterial agents, including chlorhexidine, triple dye and povidone-iodine have been shown to reduce umbilical colonization in hospitalized newborns. 89 Little is known, however, about traditional umbilical cord practices in the community, and the feasibility, acceptability and efficacy of application of topical antiseptics by caregivers, birth attendants or community health workers to prevent and treat umbilical cord infections. In rural Pakistan, application of ghee (clarified butter) heated with cow dung to the umbilical stump was associated with neonatal tetanus, but in cases in which topical antimicrobial agents were applied to promote wound healing, ghee was not used, suggesting that promotion of antimicrobial applications as a substitute for ghee might be an effective strategy in this setting. 93 No randomized controlled, community-based data are available on the impact of antimicrobial applications to the umbilical cord, compared to either routine care in the community or clean cord care on rates of umbilical cord infections and neonatal sepsis.
Neonatal Infections
Community-based studies to identify the agents of neonatal infections. Infections account for 30% to 50% of all neonatal deaths in developing countries, with pneumonia, tetanus, sepsis and diarrhea the most common causes. 3, 10 Knowledge of the etiology of infectious diseases in neonates in developing countries is based almost entirely on studies of hospitalized infants or on retrospective, verbal autopsy-based surveys in the community, neither of which may accurately reflect the true burden of disease in the community. To devise the most effective strategies for preventing and treating neonatal infections in developing countries (Table 6 ), identification of the etiologic agents of neonatal infections and their antimicrobial susceptibility patterns in the community must be determined on a regional basis. 88 The principal prospective study identifying the etiologic agents of community-acquired neonatal infections, based on laboratory diagnostic testing in conjunction with medical history and clinical examination, was conducted by the WHO in Ethiopia, The Gambia, Papua New Guinea, and The Philippines from 1990 to 1993. 94 This study, however, relied on evaluation of sick patients self-referred to health care facilities, did not include neonates who died at home, and may not have provided a representative sample of agents of infectious diseases in the community in many developing countries.
Recognition and management of neonates with potentially serious illness. To devise simple, inexpensive management strategies for reducing the morbidity and mortality of neonatal infections, risk factors, historical information, and clinical signs and symptoms predictive of serious neonatal infections (pneumonia, sepsis and meningitis) must be identified for use in first-line health care facilities and at home by trained caregivers and health care workers. 95 Antimicrobial regimens for treatment of neonatal infections in the community. Knowledge of the antimicrobial resistance patterns of common neonatal bacterial pathogens is essential for planning empiric antimicrobial therapy for the treatment of neonatal infections. Currently, WHO recommends that acutely infected neonates less than 2 months of age be treated in a health care facility capable of administering parenteral antibiotics (e.g., benzylpenicillin or ampicillin plus an aminoglycoside, such as gentamicin). 96, 97 Every attempt should be made to deliver this standard of care. Hospitalization and parenteral treatment of neonates is not feasible in many communities, however. Thus, alternative treatment strategies are needed, including the feasibility and efficacy of therapy in the home and treatment with oral antibiotics.
Two studies conducted in India suggest that treatment of neonatal infection in the home by trained community health workers can substantially reduce neonatal morbidity and mortality. In a treatment trial of neonatal pneumonia, village health workers and traditional birth attendants were trained in safe and hygienic delivery practices, neonatal care, and to identify neonates with pneumonia based on a simple set of clinical criteria. 98 Neonates in the intervention area with suspected pneumonia were empirically given co-trimoxazole orally for 7 days. The mortality rate among neonates with pneumonia in the intervention area was decreased by 40% compared to the neonates in the control area. In a second trial, village health workers were trained to provide health education to pregnant women, diagnose and manage birth asphyxia, identify premature and LBW (i.e., high risk) infants, provide thermal control, encourage breast feeding, administer vitamin K, treat skin infections, and identify and treat sick newborns. 10 For neonates with suspected sepsis, oral co-trimoxazole and intramuscular gentamicin were administered in the home. This package of intervention resulted in an approximately 60% reduction in neonatal mortality at an estimated cost of US$5.30 per neonate. Although promising, adaptation of this home-based care model and confirmation of the impact, feasibility and sustainability in other settings are needed.
CONCLUSIONS
The number of lives lost in the perinatal and neonatal period exceeds that of any other period in life of a similar duration. Moreover, as successes with child survival programs reduce infant and child mortality rates, the proportion of infant and under-five deaths that occur in the neonatal period is rising. Thus, in order to sustain gains in child survival made in recent decades, attention must be focused on reduction of morbidity and mortality in the newborn period.
A common misconception persists that neonatal care necessarily requires highly technical and costly interventions delivered by specialists. We believe that immediate gains in reducing neonatal health will come in large measure through implementation of simple, proven interventions during the antenatal, intrapartum and postpartum periods on a broader scale; improved understanding of traditional, home-based practices, and development of effective behavior change communication strategies to promote healthy behaviors; improved care of the LBW infant; improved prevention, recognition and management of neonatal illness, particularly birth asphyxia and infections at the community level; and integration of neonatal interventions within safe motherhood and child survival programs. Much is already known about how to effectively care for newborn infants, and operational research on how to translate this knowledge into effective programs; effectiveness trials of promising interventions; and monitoring of progress are areas of immediate need. In this review, we have also outlined a number of priority research activities to advance the state-of-the-art in newborn care. Effective implementation of newborn care, and innovative research planned in coordination with policy makers, stakeholders and program managers which addresses principal causes of morbidity and mortality and will lead to cost-effective, acceptable and sustainable interventions, particularly at the community level (Tables 1-6) , may now hold the greatest potential and promise for improving the survival and health of future generations of children.
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